We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+2.93%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$182M
AUM Growth
-$9.72M
(-5.1%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-5.28%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$1.19M |
| 2 |
Progressive
PGR
|
+$963K |
| 3 |
Hershey
HSY
|
+$960K |
| 4 |
DexCom
DXCM
|
+$934K |
| 5 |
Copart
CPRT
|
+$930K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lennar Class A
LEN
|
+$952K |
| 2 |
TJX Companies
TJX
|
+$909K |
| 3 |
Ameriprise Financial
AMP
|
+$902K |
| 4 |
Abbott
ABT
|
+$892K |
| 5 |
Home Depot
HD
|
+$885K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNA
426
Filana Therapeutics
FLNA
$42M
| $55.2K | 0.03% |
2,288
-887
| -28% | -$24.6K |
|
427
Arcus Biosciences
RCUS
$3.33B
| $54.9K | 0.03% |
3,010
-1,156
| -28% | -$22.1K |
|
428
Adicet Bio
ACET
$77.6M
| $54.8K | 0.03% |
594
-229
| -28% | -$28.7K |
|
|
SGMO
429
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $51.6K | 0.03% |
29,327
-11,273
| -28% | -$32.2K |
|
430
PMV Pharmaceuticals
PMVP
$57.1M
| $49.7K | 0.03% |
10,422
-4,003
| -28% | -$28.2K |
|
431
Nkarta
NKTX
$152M
| $49.1K | 0.03% |
13,821
-5,314
| -28% | -$25.2K |
|
432
Inovio Pharmaceuticals
INO
$85.6M
| $44.4K | 0.02% |
4,509
-1,733
| -28% | -$29.5K |
|
|
KZR
433
DELISTED
Kezar Life Sciences
KZR
| $43.9K | 0.02% |
1,404
-539
| -28% | -$31.2K |
|
|
TVRD
434
Tvardi Therapeutics
TVRD
$20.1M
| $42.5K | 0.02% |
241
-92
| -28% | -$30.8K |
|
435
ALX Oncology
ALXO
$262M
| $40.8K | 0.02% |
9,019
-3,465
| -28% | -$26.3K |
|
436
Novavax
NVAX
$1.21B
| $40.7K | 0.02% |
5,873
-2,256
| -28% | -$20.8K |
|
437
Altimmune
ALT
$568M
| $39.6K | 0.02% |
9,389
-3,604
| -28% | -$42.8K |
|
438
C4 Therapeutics
CCCC
$389M
| $38.8K | 0.02% |
12,350
-4,752
| -28% | -$28K |
|
439
Fate Therapeutics
FATE
$275M
| $37.5K | 0.02% |
6,585
-2,528
| -28% | -$15.3K |
|
440
ImmunityBio
IBRX
$7.15B
| $27.3K | 0.02% |
15,009
-5,773
| -28% | -$17.9K |
|
441
Apple
AAPL
$4.97T
| – | – |
-5,247
| Closed | -$682K |
|
442
Arbor Realty Trust
ABR
$977M
| – | – |
-31,669
| Closed | -$418K |
|
|
443
Abbott
ABT
$188B
| – | – |
-8,125
| Closed | -$892K |
|
444
Accenture
ACN
$106B
| – | – |
-2,865
| Closed | -$764K |
|
445
Alamos Gold
AGI
$12B
| – | – |
-60,068
| Closed | -$607K |
|
|
446
Ameriprise Financial
AMP
$47.8B
| – | – |
-2,897
| Closed | -$902K |
|
447
Aon
AON
$80.6B
| – | – |
-2,760
| Closed | -$828K |
|
448
Algonquin Power & Utilities
AQN
$4.59B
| – | – |
-33,698
| Closed | -$220K |
|
449
Avista
AVA
$3.43B
| – | – |
-10,575
| Closed | -$469K |
|
450
AvalonBay Communities
AVB
$27.5B
| – | – |
-2,278
| Closed | -$368K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, Virtus ETF Advisers held 508 positions worth $182M, down 5.1% from $191M the previous quarter. Its ten largest holdings account for 6.2% of the portfolio.
Virtus ETF Advisers withdrew a net $9.6M in Q1 2023, closing 68 positions and reducing 215 holdings. Its most notable exit was Lennar Class A, an estimated $952K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Financials and Technology.
Against the trend, Virtus ETF Advisers opened a new position in Dow Inc worth $1.16M.
- Virtus ETF Advisers's largest Q1 2023 buy was Dow Inc: 21,099 shares worth $1.16M.
- Virtus ETF Advisers added most to Devon Energy in Q1 2023, an estimated $447K increase.
- Virtus ETF Advisers's biggest Q1 2023 reduction was LyondellBasell Industries, cutting an estimated $514K.
- Virtus ETF Advisers fully exited Lennar Class A in Q1 2023, selling an estimated $952K.
- Virtus ETF Advisers's ten largest holdings make up 6.2% of its $182M portfolio in Q1 2023.
- Virtus ETF Advisers opened 65 new positions and closed 68 in Q1 2023.
- Virtus ETF Advisers's portfolio value fell 5.1% quarter-over-quarter to $182M.
Based on Virtus ETF Advisers's 13F filing for Q1 2023, filed 15 May 2023.